The deal brings Dark Blue's preclinical oncology products, including an MLLT1/3-targeted agent for leukemias, into Amgen's portfolio.
The Edit is Chase Travel’s collection of luxury hotels and resorts. Bookings made with a hotel in The Edit collection include ...
The Company enters 2026 with Multiple Phase 2 Catalysts collectively representing ~$8 billion in potential market ...
HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food ...
Novo Nordisk is my top opportunity for 2026, driven by multiple catalysts and a compelling valuation. The Wegovy pill's FDA ...
Eli Lilly and Company rated Buy: incretin/obesity growth, ZEPBOUND & orforglipron access strategy, pipeline deals, ...
Study Finds on MSN
Africa Likely Birthplace Of Modern Humans, Moroccan Fossils Suggest
Genetic evidence suggests the last shared ancestor of present-day humans, as well as ancient Neanderthals and Denisovans, ...
This valuable study links psychological theories of chunking with a physiological implementation based on short-term synaptic plasticity and synaptic augmentation. The theoretical derivation for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback